Jun 2, 2020
The focus in healthcare shifted from volume-based to value-based treatment, forcing the pharma companies to think the path ahead for sustained growth and profitability while maximizing patient outcomes. General health and wellness apps for patient education, side effect management, and medication compliance are ineffective and don’t lead to improved outcomes. How are the business and IT leaders at pharma companies collaborating to define and realize a holistic, value-based, and digital-enabled beyond and around the pill strategy that leads to improved value contribution and competitive advantage for their organizations?
Guest 1 : Gyan Pandey
Title : Global and Group CIO, Aurobindo Pharma Limited
For more details and related content :